Hybio Pharmaceutical

Chinese pharmaceutical company and CDMO. First listed peptide company in China on Shenzhen Stock Exc

Hybio Pharmaceutical is listed as a CDMO in the peptide supply chain, serving Asia markets from China. As a direct manufacturer, this supplier controls its own production process from synthesis through purification and quality control release testing. Verification is based on publicly available information and cross-referenced against industry databases. This supplier has a strong confidence score, indicating a high level of verification and reliability for B2B sourcing.